RELIANCINS: Emphasis of Matter01 Apr 2026
The auditor of the company has given the Emphasis of Matter paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/RELIANCINS_2025.pdf
RELIANCINS: Resumption after Record Date31 Mar 2026
Trading of the shares of the company will resume on 01.04.2026.
RELIANCINS: Suspension for Record Date30 Mar 2026
Trading of the shares of the company will remain suspended on record date i.e., 31.03.2026.
RELIANCINS: Spot News25 Mar 2026
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 29.03.2026 to 30.03.2026 and trading of the shares will remain suspended on record date i.e., 31.03.2026.
RELIANCINS: Dividend Declaration01 Mar 2026
The Board of Directors has recommended 30% cash dividend for the year ended on 31-Dec-2025. Date of AGM: 30-Apr-2026, Time: 11:00 AM, Venue: Virtually using Digital Platform. Record Date: 31-Mar-2026. (cont.)
RELIANCINS: Price Limit Open01 Mar 2026
There will be no price limit on the trading of the shares of the Company today (01.03.2026) following its corporate declaration.
RELIANCINS: Board Meeting schedule under LR 19(1)19 Feb 2026
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 26, 2026 at 2:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2025.
RELIANCINS: Q3 Financials30 Oct 2025
(Q3 Un-audited): EPS was Tk. 2.57 for July-September 2025 as against Tk. 2.30 for July-September 2024; EPS was Tk. 7.96 for January-September 2025 as against Tk. 6.93 for January-September 2024. NOCFPS was Tk. 8.70 for January-September 2025 as against Tk. 5.68 for January-September 2024. NAV per share was Tk. 76.62 as on September 30, 2025 and Tk. 69.59 as on December 31, 2024.
RELIANCINS: Board Meeting schedule under LR 16(1)23 Oct 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 29, 2025 at 2:45 PM to consider, among others, Un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2025.
RELIANCINS: Name Change of the Company25 Sept 2025
Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Reliance Insurance PLC.' instead of 'Reliance Insurance Limited' with effect from September 28, 2025. Other information (except name) will remain unchanged.
RELIANCINS: Q2 Financials30 Jul 2025
(Q2 Un-audited): EPS was Tk. 3.12 for April-June 2025 as against Tk. 2.67 for April-June 2024; EPS was Tk. 5.39 for January-June 2025 as against Tk. 4.63 for January-June 2024. NOCFPS was Tk. 16.74 for January-June 2025 as against Tk. 10.31 for January-June 2024. NAV per share was Tk. 71.00 as on June 30, 2025 and Tk. 69.59 as on December 31, 2024. Reasons for deviation in EPS, NOCFPS and NAVPS: EPS has increased due to increase of premium income and investment income. (cont.)
RELIANCINS: Board Meeting schedule under LR 16(1)23 Jul 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 29, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2025.
RELIANCINS: Credit Rating Result02 Jul 2025
Credit Rating Information and Services Limited (CRISL) has assigned the rating of the Company as "AAA" in the long term along with Stable outlook in consideration of its audited financials up to December 31, 2024; unaudited financials up to March 31, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
RELIANCINS: Q1 Financials15 May 2025
(Q1 Un-audited): EPS was Tk. 2.27 for January-March 2025 as against Tk. 1.96 for January-March 2024. NOCFPS was Tk. 7.84 for January-March 2025 as against Tk. 2.41 for January-March 2024. NAV per share was Tk. 68.61 as on March 31, 2025 and Tk. 69.59 as on December 31, 2024. (cont.)
RELIANCINS: Board Meeting schedule under LR 16(1)07 May 2025
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 14, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2025.
RELIANCINS: Dividend Disbursement05 May 2025
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2024 to the respective shareholders.